VOLUVEN
Google image searchProduct monograph
Active ingredient
hydroxyethyl starch 130/0.4, 6 %
DIN: 02278057
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: 6% HYDROXYETHYL STARCH 130/0.4 IN 0.9% SODIUM CHLORIDE INJECTION
Schedule: Prescription
Company: FRESENIUS KABI CANADA LTD
Date: 18-APR-2015
ATC:
- B05 — BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS (ATC, ATC/DDD, )
- B05A — BLOOD AND RELATED PRODUCTS (ATC, ATC/DDD)
- B05AA — Blood substitutes and plasma protein fractions (ATC, ATC/DDD)
- B05AA07 — HYDROXYETHYLSTARCH (ATC/DDD)
Reference brand drug: Volulyte, Voluven
